These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34299041)

  • 1. A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η
    De Palo A; Draca D; Murrali MG; Zacchini S; Pampaloni G; Mijatovic S; Maksimovic-Ivanic D; Marchetti F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
    Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
    Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
    J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand.
    Novohradsky V; Liu Z; Vojtiskova M; Sadler PJ; Brabec V; Kasparkova J
    Metallomics; 2014 Mar; 6(3):682-90. PubMed ID: 24448555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities and differences in d
    Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
    J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
    Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
    Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph
    Ludwig G; Ranđelović I; Dimić D; Komazec T; Maksimović-Ivanić D; Mijatović S; Rüffer T; Kaluđerović GN
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.
    Li J; Guo L; Tian Z; Tian M; Zhang S; Xu K; Qian Y; Liu Z
    Dalton Trans; 2017 Nov; 46(44):15520-15534. PubMed ID: 29090698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrosulfide Adducts of Organo-Iridium Anticancer Complexes.
    Štarha P; Habtemariam A; Romero-Canelón I; Clarkson GJ; Sadler PJ
    Inorg Chem; 2016 Mar; 55(5):2324-31. PubMed ID: 26863200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes.
    Liu Z; Salassa L; Habtemariam A; Pizarro AM; Clarkson GJ; Sadler PJ
    Inorg Chem; 2011 Jun; 50(12):5777-83. PubMed ID: 21618978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
    Brissos RF; Clavero P; Gallen A; Grabulosa A; Barrios LA; Caballero AB; Korrodi-Gregório L; Pérez-Tomás R; Muller G; Soto-Cerrato V; Gamez P
    Inorg Chem; 2018 Dec; 57(23):14786-14797. PubMed ID: 30444630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
    Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
    Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
    Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.
    Hearn JM; Romero-Canelón I; Qamar B; Liu Z; Hands-Portman I; Sadler PJ
    ACS Chem Biol; 2013; 8(6):1335-43. PubMed ID: 23618382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of mixed-ligand cyclometalated iridium(III)-quinoline complexes.
    Yang Y; Wang CM; Pan FH; Qin QP; Xie QJ; Chen Q; Liang H
    Dalton Trans; 2021 Nov; 50(44):16273-16280. PubMed ID: 34730150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands.
    Yang Y; Guo L; Ge X; Shi S; Gong Y; Xu Z; Zheng X; Liu Z
    J Inorg Biochem; 2019 Feb; 191():1-7. PubMed ID: 30445339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.